{"id":"https://openalex.org/W2199534893","doi":"https://doi.org/10.1016/j.jphs.2015.11.002","title":"Dopamine inhibits lipopolysaccharide-induced nitric oxide production through the formation of dopamine quinone in murine microglia BV-2 cells","display_name":"Dopamine inhibits lipopolysaccharide-induced nitric oxide production through the formation of dopamine quinone in murine microglia BV-2 cells","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-17","ids":{"openalex":"https://openalex.org/W2199534893","doi":"https://doi.org/10.1016/j.jphs.2015.11.002","mag":"2199534893","pmid":"https://pubmed.ncbi.nlm.nih.gov/26908040"},"language":"en","primary_location":{"id":"doi:10.1016/j.jphs.2015.11.002","doi":"https://doi.org/10.1016/j.jphs.2015.11.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2015.11.002","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861315002236/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2199534893"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S1347861315002236/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007844469","display_name":"Yasuhiro Yoshioka","orcid":"https://orcid.org/0000-0002-6827-9701","observed_orcids":["https://orcid.org/0000-0002-6827-9701"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yasuhiro Yoshioka","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan. Electronic address: yoshioka@pharm.setsunan.ac.jp","Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan. Electronic address: yoshioka@pharm.setsunan.ac.jp","institution_ids":["https://openalex.org/I102826571"]},{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043449306","display_name":"Yuta Sugino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuta Sugino","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055821060","display_name":"Azusa Tozawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Azusa Tozawa","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000292653","display_name":"Akiko Yamamuro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akiko Yamamuro","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015125428","display_name":"Atsushi Kasai","orcid":"https://orcid.org/0000-0002-1612-3078","observed_orcids":["https://orcid.org/0000-0002-1612-3078"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsushi Kasai","raw_affiliation_strings":["Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, and Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Interdisciplinary Program for Biomedical Sciences, Institute for Academic Initiatives, and Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011261297","display_name":"Yuki Ishimaru","orcid":"https://orcid.org/0000-0002-6767-7628","observed_orcids":["https://orcid.org/0000-0002-6767-7628"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuki Ishimaru","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101027388","display_name":"Sadaaki Maeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sadaaki Maeda","raw_affiliation_strings":["Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan","institution_ids":["https://openalex.org/I102826571"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5007844469"],"corresponding_institution_ids":["https://openalex.org/I102826571"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":{"value":2070,"currency":"USD","value_usd":2070},"fwci":0.8505,"has_fulltext":true,"cited_by_count":20,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.68013338,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"130","issue":"2","first_page":"51","last_page":"59"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-quinone","display_name":"dopamine quinone","score":0.9240000247955322},{"id":"https://openalex.org/keywords/nitric-oxide-production","display_name":"nitric oxide production","score":0.9459999799728394},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/bv2-cells","display_name":"BV-2 cells","score":0.9909999966621399},{"id":"https://openalex.org/keywords/dopamine-oxidation","display_name":"dopamine oxidation","score":0.6549999713897705},{"id":"https://openalex.org/keywords/tyrosinase","display_name":"tyrosinase","score":0.9769999980926514},{"id":"https://openalex.org/keywords/n-acetylcysteine","display_name":"N-acetylcysteine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dopamine-d1-and-d2-receptors","display_name":"dopamine D1 and D2 receptors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.7281011939048767},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.7051399946212769},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6940001249313354},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.6761086583137512},{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.6382629871368408},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6355299949645996},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44625455141067505},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4451790153980255},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.39830565452575684},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3353852927684784},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33174359798431396},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26372531056404114},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2608689069747925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25344741344451904},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.21469449996948242},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18354028463363647},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.10008659958839417},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000111","descriptor_name":"Acetylcysteine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014442","descriptor_name":"Monophenol Monooxygenase","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jphs.2015.11.002","doi":"https://doi.org/10.1016/j.jphs.2015.11.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2015.11.002","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861315002236/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:26908040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26908040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:15d66dd86fde45bc82b3329b143a6597","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/15d66dd86fde45bc82b3329b143a6597","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 130, Iss 2, Pp 51-59 (2016)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jphs.2015.11.002","doi":"https://doi.org/10.1016/j.jphs.2015.11.002","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jphs.2015.11.002","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1347861315002236/pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8199999928474426,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311022","display_name":"Universit\u00e0 Degli Studi di Modena e Reggio Emila","ror":"https://ror.org/02d4c4y02"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2199534893.pdf","grobid_xml":"https://content.openalex.org/works/W2199534893.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W85036947","https://openalex.org/W1497064282","https://openalex.org/W1514135333","https://openalex.org/W1534880720","https://openalex.org/W1544469036","https://openalex.org/W1781217464","https://openalex.org/W1837313853","https://openalex.org/W1925492557","https://openalex.org/W1977154945","https://openalex.org/W1984951531","https://openalex.org/W1987389224","https://openalex.org/W1988442264","https://openalex.org/W1998911644","https://openalex.org/W2011564032","https://openalex.org/W2012191233","https://openalex.org/W2018109459","https://openalex.org/W2028581467","https://openalex.org/W2033542384","https://openalex.org/W2034770202","https://openalex.org/W2036328607","https://openalex.org/W2036945043","https://openalex.org/W2041407419","https://openalex.org/W2042095676","https://openalex.org/W2047557745","https://openalex.org/W2051509131","https://openalex.org/W2055487345","https://openalex.org/W2055890899","https://openalex.org/W2066256031","https://openalex.org/W2076276430","https://openalex.org/W2077070321","https://openalex.org/W2090804892","https://openalex.org/W2096557101","https://openalex.org/W2103218010","https://openalex.org/W2103738800","https://openalex.org/W2108999152","https://openalex.org/W2109759840","https://openalex.org/W2120701384","https://openalex.org/W2150792870","https://openalex.org/W2170444099","https://openalex.org/W2211987820","https://openalex.org/W4313333801"],"related_works":["https://openalex.org/W2908951486","https://openalex.org/W3206697378","https://openalex.org/W2990704829","https://openalex.org/W1988442264","https://openalex.org/W4396746233","https://openalex.org/W2484544415","https://openalex.org/W4226264658","https://openalex.org/W1558382332","https://openalex.org/W1978791886","https://openalex.org/W2001418709"],"abstract_inverted_index":{"Dopamine":[0],"(DA)":[1],"has":[2],"been":[3],"suggested":[4],"to":[5,125],"modulate":[6],"functions":[7],"of":[8,19,32,64,116,123,133,151],"glial":[9],"cells":[10],"including":[11],"microglial":[12,22,43],"cells.":[13,60,155],"To":[14],"reveal":[15],"the":[16,25,30,103,114,121,130,149],"regulatory":[17],"role":[18],"DA":[20,33,49,65,80,96,110,124,126,134,143],"in":[21,24,41,58,153],"function,":[23],"present":[26],"study,":[27],"we":[28],"investigated":[29],"effect":[31,63,115,132],"on":[34,66,135],"lipopolysaccharide":[35],"(LPS)-induced":[36],"nitric":[37],"oxide":[38],"(NO)":[39],"production":[40,57,69,147],"murine":[42],"cell":[44],"line":[45],"BV-2.":[46],"Pretreatment":[47],"with":[48,87],"for":[50],"24":[51],"h":[52],"concentration-dependently":[53],"attenuated":[54],"LPS-induced":[55,67,104,136,145],"NO":[56,68,105,137,146],"BV-2":[59,154],"The":[61],"inhibitory":[62,131],"was":[70],"not":[71,101],"inhibited":[72,113],"by":[73],"SCH-23390":[74],"and":[75,78,91,94],"sulpiride,":[76],"D1-like":[77,93],"D2-like":[79,95],"receptor":[81,97],"antagonists,":[82],"respectively.":[83],"In":[84],"addition,":[85],"pretreatment":[86],"(-)-(6aR,12bR)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-a]phenanthridin":[88],"(CY":[89],"208-243)":[90],"bromocriptine,":[92],"agonists,":[98],"respectively,":[99],"did":[100],"affect":[102],"production.":[106,138],"N-Acetylcysteine,":[107],"which":[108,119],"inhibits":[109],"oxidation,":[111],"completely":[112],"DA.":[117],"Tyrosinase,":[118],"catalyzes":[120],"oxidation":[122],"quionone":[127],"(DAQ),":[128],"accelerated":[129],"These":[139],"results":[140],"suggest":[141],"that":[142],"attenuates":[144],"through":[148],"formation":[150],"DAQ":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2199534893","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
